Pyridine → HCID 59548739, compound
Reaction equation
[CH3:1][C:2]1[CH:6]=[C:5]([CH3:7])[N:4]([CH2:8][C:9]([OH:11])=O)[N:3]=1.[N:12]1C=CC=CC=1.[Cl:18][C:19]1[CH:20]=[C:21]([CH:39]=[CH:40][CH:41]=1)[C:22]([NH:24][C:25]1[CH:30]=[C:29]([Cl:31])[CH:28]=C[C:26]=1[N:32]1[CH2:38][CH2:37][CH2:36][NH:35][CH2:34][CH2:33]1)=[O:23]>CN(C)C=O>[Cl:18][C:19]1[CH:20]=[C:21]([CH:39]=[CH:40][CH:41]=1)[C:22]([NH:24][C:25]1[C:26]([N:32]2[CH2:38][CH2:37][CH2:36][N:35]([C:9](=[O:11])[CH2:8][N:4]3[C:5]([CH3:7])=[CH:6][C:2]([CH3:1])=[N:3]3)[CH2:34][CH2:33]2)=[N:12][CH:28]=[C:29]([Cl:31])[CH:30]=1)=[O:23]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To solution of (3,5-dimethyl-pyrazol-1-yl)-acetic acid (0.010 g, 0.068 mmol) in N,N-dimethylformamide (2 mL) is added 0.006 mL (0.071 mmol) of pyridine followed by) tetramethyluroniumhydroxybenzotriazolehexaflourophosphate (0.123 g, 0.324 mmol). The mixture stirred for 1 hour. To this is added 3-chloro-N-(5-chloro-2-[1,4]diazepan-1-yl-phenyl)-benzamide (0.025 g, 0.068 mmol). The mixture is allowed to stir overnight. The mixture is concentrated under reduced pressure and is purified by reverse phase HPLC to provide 0.010 g of 3-chloro-N-(5-chloro-2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-[1,4]diazepan-1-yl}-pyridin-3-yl)-benzamide in 29% yield. MS MH+=501.8
Workup
- stirringto stir overnight
- concentrationThe mixture is concentrated under reduced pressure
- customis purified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-a75d4433e7dd486b809a91c4751e7489
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08362249B2
Reaction notes
Loading…